Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Summary

The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy

Timeline

Start

2021-06-08

Primary completion

2025-08-22

Completion

2026-11-06

Drugs

Indications